Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
Add Company

Oasmia Pharmaceutical AB

Vallongatan 1
Uppsala
SE-752 28
Sweden
PH: +46 (18) 50 54 40
Fax: +46 (18) 51 08 73
Email: info@oasmia.com
Visit Oasmia Pharmaceutical AB Website or Request Quote for Further Information

Company Background

Oasmia is developing a new generation of drugs with emphasis on human and veterinary oncology. Our main business activity focuses on improving product life cycles and the versatility of current pharmaceuticals. In-house research in nanotechnology and a long-term working basis can be seen as a guarantee for reaching our highly set goals.

In addition to strategic investments in oncology we also have a number of promising patents and candidates in therapy fields such as infection, asthma and neurology.

Ask A Question

Do you have a question you'd like to ask this Supplier?

Leave your feedback
Submit